Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
-
+
ES11 - Joint IASLC-ESTRO Session - Integration of Radiotherapy for Optimal Patient Outcomes
- Type: Education Session
- Track: N/A
- Presentations: 8
- Moderators:Alexander Louie
- Coordinates: 8/07/2022, 14:30 - 15:30, Lehar 1
-
+
Session Moderator
14:30 - 14:30 | Author(s): Alexander Louie
- Abstract
Loading... -
+
ES11.01 - Session Introduction
14:30 - 14:31 | Author(s): Alexander Louie
- Abstract
Loading... -
+
Session Moderator
14:30 - 14:30 | Author(s): Corinne Faivre-Finn
- Abstract
Loading... -
+
ES11.02 - Session Introduction
14:31 - 14:32 | Author(s): Corinne Faivre-Finn
- Abstract
Loading... -
+
ES11.03 - What Is the Role of Radiotherapy in the Immunotherapy Era for Resectable NSCLC?
14:32 - 14:44 | Author(s): Shankar Siva
- Abstract
Loading... -
+
ES11.05 - What are the Challenges of Pneumonitis in the Multimodality Radical Treatment Era?
14:44 - 14:56 | Author(s): Andrew Bang
- Abstract
Loading... -
+
ES11.06 - The Increasing Role of Re-Irradiation: How Do We Keep It Safe?
14:56 - 15:08 | Author(s): SARA RAMELLA
- Abstract
Loading... -
+
ES11.07 - Live Q&A
15:08 - 15:30
- Abstract
Loading...
-
+
MA04 - Pulmonology, Radiology, and Staging
- Type: Mini Oral
- Track: Pulmonology, Radiology, and Staging
- Presentations: 13
- Moderators:Mir Alireza Hoda
- Coordinates: 8/07/2022, 14:30 - 15:30, Strauss 3
-
+
MA04.01 - Session Introduction
14:30 - 14:31 | Author(s): Mir Alireza Hoda
- Abstract
Loading... -
+
MA04.02 - Session Introduction
14:31 - 14:32 | Author(s): Pieter Postmus
- Abstract
Loading... -
+
MA04.03 - Reconsidering T Classification for T3/T4 Non-small Cell Lung Cancer with Additional Nodule(s)
14:32 - 14:37 | Author(s): Fang Wang
- Abstract
Loading... -
+
MA04.04 - The Ground-Glass Component Status Combined with the Clinical T Descriptor Predicts Prognosis and Genomic Alterations in NSCLC
14:37 - 14:42 | Author(s): Yukihiro Yoshida
- Abstract
Loading... -
+
MA04.05 - T3 Defining Features Influence Long Term Survival after Resection of T3N0M0 NSCLC
14:42 - 14:47 | Author(s): Paula A Ugalde Figueroa
- Abstract
Loading... -
+
MA04.06 - Discussant
14:47 - 14:57 | Author(s): Frank Detterbeck
- Abstract
Loading... -
+
MA04.07 - A Controlled Study of Pathological T- staging and Imaging T-staging of NSCLC Based on Artificial Intelligence
14:57 - 15:02 | Author(s): Yuanyong Wang
- Abstract
Loading... -
+
MA04.08 - Navigation Bronchoscopy Mediated Sentinel Lymph Node Procedure: an Explorative Study in Ex-vivo Lung Cancer Specimens
15:02 - 15:07 | Author(s): Desi Karina Maria ter Woerds
- Abstract
Loading... -
+
MA04.09 - The Incidence and Predictors of Unsuspected Brain Metastases in Patients with Stage IA NSCLC
15:07 - 15:12 | Author(s): Camille Anne Mathey-Andrews
- Abstract
Loading... -
+
MA04.10 - Discussant
15:12 - 15:22 | Author(s): Rudolf M Huber
- Abstract
Loading... -
+
MA04.11 - Live Q&A
15:22 - 15:30
- Abstract
Loading... -
+
Session Moderator
15:22 - 15:30 | Author(s): Mir Alireza Hoda
- Abstract
Loading... -
+
Session Moderator
15:22 - 15:30 | Author(s): Pieter Postmus
- Abstract
Loading...
-
+
OA03 - Molecular Targeted Treatments
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Presentations: 11
- Moderators:Andrew Ciupek
- Coordinates: 8/07/2022, 14:30 - 15:40, Hall C7
-
+
OA03.01 - Session Introduction
14:30 - 14:31 | Author(s): Andrew Ciupek
- Abstract
Loading... -
+
OA03.02 - Session Introduction
14:31 - 14:32 | Author(s): David R. Gandara
- Abstract
Loading... -
+
OA03.03 - Sotorasib in Combination with RMC-4630, a SHP2 Inhibitor, in KRAS p.G12C-Mutated NSCLC and Other Solid Tumors
14:32 - 14:42 | Author(s): Gerald Falchook
- Abstract
Loading... -
+
OA03.04 - Phase I A Study to Evaluate GDC-6036 Monotherapy in Patients with Non-small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation
14:42 - 14:52 | Author(s): Adrian Sacher
- Abstract
Loading... -
+
OA03.05 - Tepotinib in Patients with MET Exon 14 (METex14) Skipping NSCLC: Primary Analysis of the Confirmatory VISION Cohort C
14:52 - 15:02 | Author(s): Michael Thomas
- Abstract
Loading... -
+
OA03.06 - CodeBreaK 100/101: First Report of Safety/Efficacy of Sotorasib in Combination with Pembrolizumab or Atezolizumab in Advanced KRAS p.G12C NSCLC
15:02 - 15:12 | Author(s): Bob T. Li
- Abstract
Loading... -
+
OA03.07 - Safety and Efficacy of D-1553 in Patients with KRAS G12C Mutated Non-Small Cell Lung Cancer: A Phase 1 Trial
15:12 - 15:22 | Author(s): Shun Lu
- Abstract
Loading... -
+
OA03.08 - Discussant
15:22 - 15:32 | Author(s): Helena Linardou
- Abstract
Loading... -
+
OA03.09 - Live Q&A
15:32 - 15:40
- Abstract
Loading... -
+
Session Moderator
15:32 - 15:40 | Author(s): Andrew Ciupek
- Abstract
Loading... -
+
Session Moderator
15:32 - 15:40 | Author(s): David R. Gandara
- Abstract
Loading...
-
+
OA04 - Mesothelioma Under the Looking Glass
- Type: Oral
- Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies
- Presentations: 10
- Moderators:Joachim G.J.V. Aerts
- Coordinates: 8/07/2022, 14:30 - 15:30, Hall C8
-
+
OA04.01 - Session Introduction
14:30 - 14:31 | Author(s): Joachim G.J.V. Aerts
- Abstract
Loading... -
+
OA04.02 - Session Introduction
14:31 - 14:32 | Author(s): Anne Tsao
- Abstract
Loading... -
+
OA04.03 - Multi-omic Analysis of Malignant Pleural Mesothelioma PDXs Reveal Pathway Alterations and Therapeutic Targets
14:32 - 14:42 | Author(s): Triparna Sen
- Abstract
Loading... -
+
OA04.04 - Association of Novel microRNAs With Diagnosis and Histology of Malignant Pleural Mesothelioma
14:42 - 14:52 | Author(s): Michaela B Kirschner
- Abstract
Loading... -
+
OA04.05 - MESOMICS Project: Using Whole-Genome Sequencing Data to Fill the Gaps in Malignant Pleural Mesothelioma Molecular Studies
14:52 - 15:02 | Author(s): Lise Mangiante
- Abstract
Loading... -
+
OA04.06 - PEMbrolizumab Plus Lenvatinib In Second And Third Line Malignant Pleural MEsotheLiomA Patients: A Single Arm Phase II Study (PEMMELA)
15:02 - 15:12 | Author(s): Li-Anne Huaqing Douma
- Abstract
Loading... -
+
Session Moderator
15:02 - 15:12 | Author(s): Joachim G.J.V. Aerts
- Abstract
Loading... -
+
Session Moderator
15:02 - 15:12 | Author(s): Anne Tsao
- Abstract
Loading... -
+
OA04.07 - Discussant
15:12 - 15:22 | Author(s): Giovanni Luca Ceresoli
- Abstract
Loading... -
+
OA04.08 - Live Q&A
15:22 - 15:40
- Abstract
Loading...
-
+
ES12 - Surgical Issues in Multimodality Treatments for Early Stage NSCLC
- Type: Education Session
- Track: Early Stage Non-small Cell Lung Cancer - Surgery
- Presentations: 9
- Moderators:Tomaz Stupnik
- Coordinates: 8/07/2022, 15:45 - 16:45, Hall C1
-
+
ES12.01 - Session Introduction
15:45 - 15:46 | Author(s): Tomaz Stupnik
- Abstract
Loading... -
+
Session Moderator
15:45 - 15:46 | Author(s): Tomaz Stupnik
- Abstract
Loading... -
+
Session Moderator
15:45 - 15:46 | Author(s): Mir Alireza Hoda
- Abstract
Loading... -
+
ES12.02 - Session Introduction
15:46 - 15:47 | Author(s): Mir Alireza Hoda
- Abstract
Loading... -
+
ES12.03 - The Role of Minimally Invasive Surgery in Multimodality Setting
15:47 - 15:59 | Author(s): Alan D. L. Sihoe
- Abstract
Loading... -
+
ES12.04 - Surgical Challenges of Neoadjuvant Immunotherapy
15:59 - 16:11 | Author(s): Valerie Williams Rusch
- Abstract
Loading... -
+
ES12.05 - Assessment of Resectability after Chemotherapy with Immunocheckpoint Inhibitor or Molecular Targeted Therapies
16:11 - 16:23 | Author(s): Giulia Veronesi
- Abstract
Loading... -
+
ES12.06 - Optimum Surgical Staging and Tissue Acquisition for Adjuvant Immunotherapy and Targeted Treatments
16:23 - 16:35 | Author(s): Paula A Ugalde Figueroa
- Abstract
Loading... -
+
ES12.07 - Live Q&A
16:35 - 16:45
- Abstract
Loading...
-
+
ES13 - Mesothelioma
- Type: Education Session
- Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies
- Presentations: 9
- Moderators:Paolo Bironzo
- Coordinates: 8/07/2022, 15:45 - 16:45, Hall C2
-
+
ES13.01 - Session Introduction
15:45 - 15:46 | Author(s): Paolo Bironzo
- Abstract
Loading... -
+
ES13.02 - Session Introduction
15:46 - 15:47 | Author(s): Leah Backhus
- Abstract
Loading... -
+
ES13.03 - Update in the Pathologic Diagnosis in Mesothelioma
15:47 - 15:59 | Author(s): Francoise Blanche Galateau Salle
- Abstract
Loading... -
+
ES13.04 - First Line Treatment: Optimal Choice for Which Patient?
15:59 - 16:11 | Author(s): Wanda Cui
- Abstract
Loading... -
+
ES13.05 - Second Line and Beyond
16:11 - 16:23 | Author(s): Dean Anthony Fennell
- Abstract
Loading... -
+
ES13.06 - Targeted Therapy and Experimental Drugs
16:23 - 16:35 | Author(s): Raffit Hassan
- Abstract
Loading... -
+
ES13.07 - Live Q&A
16:35 - 16:45
- Abstract
Loading... -
+
Session Moderator
16:35 - 16:45 | Author(s): Paolo Bironzo
- Abstract
Loading... -
+
Session Moderator
16:35 - 16:45 | Author(s): Leah Backhus
- Abstract
Loading...
-
+
ES14 - Think, Think, Think?..The Importance of Thinking Holistically When Caring for Lung Cancer Patients
- Type: Education Session
- Track: Nursing and Allied Health Professionals
- Presentations: 9
- Moderators:Anne Fraser
- Coordinates: 8/07/2022, 15:45 - 16:45, Lehar 1
-
+
ES14.01 - Session Introduction
15:45 - 15:46 | Author(s): Anne Fraser
- Abstract
Loading... -
+
ES14.02 - Session Introduction
15:46 - 15:47 | Author(s): Andreas Charalambous
- Abstract
Loading... -
+
ES14.03 - Information Needs of Carers of People with Lung Cancer
15:47 - 15:59 | Author(s): Simon Dunne
- Abstract
Loading... -
+
ES14.04 - Interventions to Improve Cancer Survivorship among Indigenous Peoples and Communities
15:59 - 16:11 | Author(s): Marianne Davies
- Abstract
Loading... -
+
ES14.05 - Interventions to Limit the Impacts of Parental Lung Cancer Impact on Children
16:11 - 16:23 | Author(s): Elena Schiena
- Abstract
Loading... -
+
ES14.06 - Treating People with Comorbid Dementia: Implications for Cancer Care
16:23 - 16:35 | Author(s): Lorna McWilliams
- Abstract
Loading... -
+
ES14.07 - Live Q&A
16:35 - 16:45
- Abstract
Loading... -
+
Session Moderator
16:35 - 16:45 | Author(s): Anne Fraser
- Abstract
Loading... -
+
Session Moderator
16:35 - 16:45 | Author(s): Andreas Charalambous
- Abstract
Loading...
-
+
ES15 - Is Cytotoxic Chemotherapy in NSCLC Management Only Palliative?
- Type: Education Session
- Track: Metastatic Non-small Cell Lung Cancer - Palliative Chemotherapy
- Presentations: 10
- Moderators:Navneet Singh
- Coordinates: 8/07/2022, 15:45 - 16:45, Strauss 1/2
-
+
ES15.01 - Session Introduction
15:45 - 15:46 | Author(s): Navneet Singh
- Abstract
Loading... -
+
ES15.02 - Session Introduction
15:46 - 15:47 | Author(s): Khaled Abdel-Aziz Mohamed Kamal
- Abstract
Loading... -
+
ES15.03 - Impact of Smoking on Clinical Outcomes of Systemic Therapies
15:47 - 15:52 | Author(s): Enrica Capelletto
- Abstract
Loading... -
+
ES15.04 - Can Chemotherapy Agents Be Personalized in NSCLC?
15:52 - 16:04 | Author(s): David Planchard
- Abstract
Loading... -
+
ES15.05 - Second-Line Chemotherapy Following First-Line Mono-Immunotherapy in High PD-L1 (TPS≥50%) Advanced/Metastatic NSCLC
16:04 - 16:16 | Author(s): Sara Pilotto
- Abstract
Loading... -
+
ES15.06 - The Future of Cytotoxics in the Management of NSCLC
16:16 - 16:28 | Author(s): Sofia Baka
- Abstract
Loading... -
+
ES15.07 - Chemotherapy in Elderly NSCLC Patients: How to Play It Safe?
16:28 - 16:40 | Author(s): Rajwanth Veluswamy
- Abstract
Loading... -
+
ES15.08 - Live Q&A
16:40 - 16:45
- Abstract
Loading... -
+
Session Moderator
16:40 - 16:45 | Author(s): Navneet Singh
- Abstract
Loading... -
+
Session Moderator
16:40 - 16:45 | Author(s): Khaled Abdel-Aziz Mohamed Kamal
- Abstract
Loading...
-
+
MA05 - Immune Landscape and Molecular Profiling of Lung Cancer
- Type: Mini Oral
- Track: Tumor Biology and Biomarkers
- Presentations: 13
- Moderators:Luis Paz-Ares
- Coordinates: 8/07/2022, 15:45 - 16:45, Hall C8
-
+
MA05.01 - Session Introduction
15:45 - 15:46 | Author(s): Luis Paz-Ares
- Abstract
Loading... -
+
Session Moderator
15:45 - 15:45 | Author(s): Luis Paz-Ares
- Abstract
Loading... -
+
Session Moderator
15:45 - 15:45 | Author(s): Tina Cascone
- Abstract
Loading... -
+
MA05.02 - Session Introduction
15:46 - 15:47 | Author(s): Tina Cascone
- Abstract
Loading... -
+
MA05.03 - Utilization of Genomic Mutation Signature to Predict the Immunotherapy Response in Non-small Cell Lung Cancer
15:47 - 15:52 | Author(s): Xiaoxuan Wu
- Abstract
Loading... -
+
MA05.04 - Multiplex Phenotyping Reveals Spatial Immune Patterns in NSCLC
15:52 - 15:57 | Author(s): Max Wilhelm Backman
- Abstract
Loading... -
+
MA05.05 - Analysis of CREBBP as a Potential Biomarker for Immune Checkpoint Therapy in Solid Tumors and Its Correlation With Immune Microenvironment
15:57 - 16:02 | Author(s): Xiaoli Liu
- Abstract
Loading... -
+
MA05.07 - Intertumoral Molecular Heterogeneity of Non-small Cell Lung Cancer With MET Exon 14 Skipping
15:57 - 16:02 | Author(s): Yuchen Han
- Abstract
Loading... -
+
MA05.06 - Discussant
16:02 - 16:12 | Author(s): Fabio Pagni
- Abstract
Loading... -
+
MA05.08 - MET Exon 14 Skipping Mutation in Non-Small Cell Lung Cancer (NSCLC) by Specific Mutation, Histology, and Smoking History
16:17 - 16:22 | Author(s): Jennifer A. Marks
- Abstract
Loading... -
+
MA05.09 - Genomic Mapping of Metastatic Organotropism: Analysis of 2326 Primary and Organ-Specific Metastases in Lung Adenocarcinoma
16:22 - 16:27 | Author(s): Harry Lengel
- Abstract
Loading... -
+
MA05.10 - Discussant
16:27 - 16:37 | Author(s): Giulia Pasello
- Abstract
Loading... -
+
MA05.11 - Live Q&A
16:37 - 16:45
- Abstract
Loading...
-
+
OA05 - The Granularity of Lung Cancer Screening Implementation
- Type: Oral
- Track: Early Detection and Screening
- Presentations: 10
- Moderators:Arjun Nair
- Coordinates: 8/07/2022, 15:45 - 16:45, Hall C7
-
+
OA05.01 - Session Introduction
15:45 - 15:46 | Author(s): Arjun Nair
- Abstract
Loading... -
+
OA05.02 - Session Introduction
15:46 - 15:47 | Author(s): Ella A Kazerooni
- Abstract
Loading... -
+
OA05.03 - Incidence, Timing, and Survival of Second Primary Lung Cancer in Patients in the National Lung Screening Trial
15:47 - 15:57 | Author(s): Alexandra Potter
- Abstract
Loading... -
+
OA05.04 - A Comparison of Stage- and Histology-Specific CT Sensitivity in the NELSON Trial and the NLST
15:57 - 16:07 | Author(s): Koen de Nijs
- Abstract
Loading... -
+
OA05.05 - China Lung Cancer Screening (CLUS) Version 1.0: Mortality, Survival and Incidence Rates with Long-Term Follow-up
16:07 - 16:17 | Author(s): Fangfei Qian
- Abstract
Loading... -
+
OA05.06 - Early Diagnosis of Lung Cancer Among Younger vs. Older Adults: Widening Disparities in the Era of Lung Cancer Screening
16:17 - 16:27 | Author(s): Alexandra Leigh Potter
- Abstract
Loading... -
+
OA05.07 - Discussant
16:27 - 16:37 | Author(s): Anand Devaraj
- Abstract
Loading... -
+
Session Moderator
16:27 - 16:37 | Author(s): Arjun Nair
- Abstract
Loading... -
+
Session Moderator
16:27 - 16:37 | Author(s): Ella A Kazerooni
- Abstract
Loading... -
+
OA05.08 - Live Q&A
16:37 - 16:45
- Abstract
Loading...
first
prev
